Form D · Pharmaceuticals
Karuna Pharmaceuticals Inc
Boston, MA · CIK 0001522897
Offering snapshot reported Jun 9, 2011 · SEC filing
- Reported sold
- $600K Offering amount: $600K
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 25, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 9, 2011 | Initial | $600,000 | No comparison | 7 | SEC filing |
Offering details
- Securities
- Debt, Security to be acquired
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-161041
Source: Form D, filed Jun 9, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Eric Elenko | Director |
| Edmund Harrigan | Director, Executive |
| Stephen Muniz | Director |
| Steven Marc Paul | Director |
| Daphne Zohar | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
500 Boylston Street Suite 1600
Boston, MA, 02116
Boston, MA, 02116